The role of stereotactic body radiotherapy in hepatocellular carcinoma: guidelines and evidences

The role of stereotactic body radiotherapy in hepatocellular carcinoma: guidelines and evidences

Hepatocellular carcinoma (HCC) is a common malignancy with high mortality rates. While surgery can be curative in early-stage disease, 80% of patients cannot undergo surgical resection. Stereotactic body radiotherapy (SBRT), an emerging, non-invasive, precision treatment, has shown promising results...

Full description

Bibliographic Details
Main Authors: Yulin Hu, Caining Zhao, Ren Ji, Wenqi Chen, Qi Shen, CL Chiang, Jeff Chan, Lingyu Ma, Hongwei Yang, Tiffany Wong, Susannah Ellsworth, Chung-Mau Lo, Laura A. Dawson, Feng-Ming (Spring) Kong
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Journal of the National Cancer Center
Subjects:
Hepatocellular carcinoma
Stereotactic body radiotherapy
Guidelines
Liver local treatment
Local tumor control
Online Access:http://www.sciencedirect.com/science/article/pii/S2667005422000333

Internet

http://www.sciencedirect.com/science/article/pii/S2667005422000333

Similar Items